Matches in Wikidata for { <http://www.wikidata.org/entity/Q89813932> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q89813932 description "article scientifique publié en 2020" @default.
- Q89813932 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89813932 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89813932 description "scientific article published on 21 February 2020" @default.
- Q89813932 description "wetenschappelijk artikel" @default.
- Q89813932 description "наукова стаття, опублікована 21 лютого 2020" @default.
- Q89813932 name "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 name "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 type Item @default.
- Q89813932 label "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 label "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 prefLabel "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 prefLabel "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 P1433 Q89813932-E1687FAC-D06D-4939-A64B-5F3A96D63DDB @default.
- Q89813932 P1476 Q89813932-46460257-DF95-4C56-86C8-2E06CE0897BB @default.
- Q89813932 P2093 Q89813932-2328CBEA-A1A9-4F8B-8419-9C8E3BDD1652 @default.
- Q89813932 P2093 Q89813932-2AF22FF6-65FF-48E1-B43A-196B32010151 @default.
- Q89813932 P2093 Q89813932-2C017BC7-6BE9-4DA2-A29B-775A2DCC4992 @default.
- Q89813932 P2093 Q89813932-43B2E99A-19AB-4352-92DC-BC77463630E0 @default.
- Q89813932 P31 Q89813932-3A850C2D-ED45-4812-B7F5-2A7BCE8B3367 @default.
- Q89813932 P356 Q89813932-A1FBB1C6-2F43-4F92-A828-E85693655A77 @default.
- Q89813932 P50 Q89813932-4962B54A-952F-4BD9-A6F7-0153D6E24D59 @default.
- Q89813932 P577 Q89813932-C960878A-68D1-416C-8220-289E309CB1EA @default.
- Q89813932 P698 Q89813932-AF27E93F-8D47-48D9-9632-BAEBA64B7568 @default.
- Q89813932 P921 Q89813932-A50CFE9D-C1AF-437D-8C4C-1137500B6C8C @default.
- Q89813932 P356 FCP.12549 @default.
- Q89813932 P698 32080901 @default.
- Q89813932 P1433 Q15760364 @default.
- Q89813932 P1476 "Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity" @default.
- Q89813932 P2093 "Alaa E El-Sisi" @default.
- Q89813932 P2093 "Mohamed F Hamed" @default.
- Q89813932 P2093 "Sally E Abu-Risha" @default.
- Q89813932 P2093 "Samia S Sokkar" @default.
- Q89813932 P31 Q13442814 @default.
- Q89813932 P356 "10.1111/FCP.12549" @default.
- Q89813932 P50 Q89813928 @default.
- Q89813932 P577 "2020-02-21T00:00:00Z" @default.
- Q89813932 P698 "32080901" @default.
- Q89813932 P921 Q177094 @default.